Cite
MLA Citation
Alessandro Armuzzi et al.. “The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.” Inflammatory bowel diseases, vol. 25, no. 3, 2019, pp. 568–579. http://access.bl.uk/ark:/81055/vdc_100094073804.0x000035